Lanean...

Current approaches and future directions in the treatment of HER2-positive breast cancer

Human epidermal growth factor receptor 2 (HER2), a member of the ErbB family of transmembrane receptor tyrosine kinases, is amplified in 20–30% of invasive breast cancers. HER2 amplification is associated with metastasis and reduced survival. Two HER2-directed therapies have been approved by the Uni...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hurvitz, Sara, Hu, Yufang, O’Brien, Neil, Finn, Richard S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3835685/
https://ncbi.nlm.nih.gov/pubmed/22658319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2012.04.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!